Unichem Laboratories (UNICHEMLAB) Share Discussion | Stock forum

Unichem Laboratories

Unichem Laboratories Limited manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in India and internationally.

Industry: Pharmaceuticals

Ticker	Exchange	ISIN	Name
$UNICHEMLAB	BSE	INE351A01035	Code: 506690
$UNICHEMLAB	NSE	INE351A01035

Recent news

Fertilizers & Chemicals Travancore reports 2,795% EBITDA growth in 2020 and 9.6 pp EBITDA Margin growth from 0.49% to 10.1%

Ginni Filaments EBITDA jumped on 15.6% while Revenue decreased slightly on 1.3%

Ajel Net Income dropped on 148% while EBITDA Margin increased on 3.9 pp from -11.7% to -7.8%

Gulf Oil Corporation Net Debt / EBITDA jumped on 70.0x from 5.2x to 75.2x in 2020 while Revenue decreased on 6.3%

Royal Orchid Hotels Net Income dropped on 58.9% and Revenue increased slightly on 0.59%

Media Matrix Worldwide Net Income dropped on 95.2% and Revenue dropped on 31.1%

Sindhu Trade Links reports 250% Net Income growth in 2020 while 58.9% Revenue decline

Jay Shree Tea & Industries reports 318% EBITDA decline in 2020 and 5.2% Revenue decline

Hexaware Technologies revenue jumped on 20.1% and EBITDA Margin showed almost no change

Fertilizers & Chemicals Travancore Net Debt / EBITDA jumped on 221.9x from 13.3x to 235.2x in 2019 and Revenue increased slightly on 1.3%

Twit about UNICHEMLAB stock

Share your investment idea or question on Unichem Laboratories stock:

Latest twits on Unichem Laboratories (UNICHEMLAB)

No twits yet. Be the first to post!

Have a question about UNICHEMLAB? Ask and other investors will be eager to help you.

Have an idea about UNICHEMLAB? Share it with other investors.

Unichem Laboratories news

20-05-2016 Unichem Laboratories CAPEX jumped on 80.3% and Revenue jumped on 11.0%

09-05-2015 Unichem Laboratories reports 55.5% Net Income decline while 6.0% Revenue growth

Unichem Laboratories stock price chart

Unichem Laboratories financials

mln. INR	FY2010	FY2011	FY2012

Revenue	14,212	8,240	8,755
EBITDA	1,753	1,500	1,183
Net income	1,231	949.8	712.6
CAPEX	459.1	908.8	1,131
Debt	357.8	507.6	693.8
Cash	142.4	92.940	153.0

Unichem Laboratories news

20-05-2016 Unichem Laboratories CAPEX jumped on 80.3% and Revenue jumped on 11.0%

09-05-2015 Unichem Laboratories reports 55.5% Net Income decline while 6.0% Revenue growth

About Unichem Laboratories

Unichem Laboratories Limited manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in India and internationally. It offers various formulation products that address a range of therapeutic areas, such as cardiology, diabetology, nephrology, central nervous system, ENT, gastroenterology, dermatology/cosmetology, rheumatology, generic pharmaceutical drugs, and anti-infectives. Unichem Laboratories Limited was founded in 1944 and is based in Mumbai, India.